Abstract
Ischemic damage, chiefly of the focal type, and axonal disruption (diffuse axonal injury) are the major factors causing brain damage after human head injury. About one third of this damage may be delayed hours or days after the injury. Evidence from four animal models, each relevant to different aspects of human head injury, has shown that excitatory amino acid-induced changes are responsible for a proportion of the posttraumatic sequelae and that these effects can be blocked by EAA antagonists. This evidence is reviewed, and the implications for the conduct of human trials with EAA antagonists are discussed.
| Original language | English |
|---|---|
| Journal | Journal of Neurotrauma |
| Volume | 9 |
| Issue number | SUPPL. 2 |
| State | Published - Jan 1 1992 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Cite this
The role of glutamate antagonists for the treatment of CNS injury. / Bullock, Ross; Fujisawa, H.
In: Journal of Neurotrauma, Vol. 9, No. SUPPL. 2, 01.01.1992.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The role of glutamate antagonists for the treatment of CNS injury
AU - Bullock, Ross
AU - Fujisawa, H.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - Ischemic damage, chiefly of the focal type, and axonal disruption (diffuse axonal injury) are the major factors causing brain damage after human head injury. About one third of this damage may be delayed hours or days after the injury. Evidence from four animal models, each relevant to different aspects of human head injury, has shown that excitatory amino acid-induced changes are responsible for a proportion of the posttraumatic sequelae and that these effects can be blocked by EAA antagonists. This evidence is reviewed, and the implications for the conduct of human trials with EAA antagonists are discussed.
AB - Ischemic damage, chiefly of the focal type, and axonal disruption (diffuse axonal injury) are the major factors causing brain damage after human head injury. About one third of this damage may be delayed hours or days after the injury. Evidence from four animal models, each relevant to different aspects of human head injury, has shown that excitatory amino acid-induced changes are responsible for a proportion of the posttraumatic sequelae and that these effects can be blocked by EAA antagonists. This evidence is reviewed, and the implications for the conduct of human trials with EAA antagonists are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0026635016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026635016&partnerID=8YFLogxK
M3 - Article
VL - 9
JO - Journal of Neurotrauma
JF - Journal of Neurotrauma
SN - 0897-7151
IS - SUPPL. 2
ER -